Apollo Hospitals Q4FY23 PAT up 50.14% at Rs146crore due to lower tax burden in the current quarter

Apollo  Hospitals reported 21.3% growth in net sales revenues for the March 2023 quarter on consolidated basis at Rs4,302 crore. Revenues were marginally up 0.91% on sequential basis. For the quarter, the revenues from the healthcare services were up 18.5% yoy at Rs2,227 crore. The revenues from retail health and diagnostics vertical were up 3% at Rs308 crore while revenues from digital and pharmacy distribution was up 30.8% at Rs1,799 crore.

While the operating profits for the quarter were up 10.87% overall at Rs329 crore, the net profits grew 50.14% on yoy basis to Rs146 crore. The operating profits growth was almost 50% yoy at Rs411 crore in the healthcare services business. However, the retail health and diagnostics vertical saw operating profits fall by nearly three-fourth while the digital health and pharmacy business actually dipped into an operating loss of Rs-83 crore. Net profit growth was largely on account of lower tax burden in the quarter.

Financial highlights for Mar-23 compared yoy and sequentially

 Apollo Hospitals    

Rs in Crore

Mar-23

Mar-22

YOY

Dec-22

QOQ

Total Income (Rs cr)

₹ 4,302

₹ 3,546

21.31%

₹ 4,264

0.91%

Operating Profit (Rs cr)

₹ 329

₹ 297

10.87%

₹ 352

-6.50%

Net Profit (Rs cr)

₹ 146

₹ 97

50.14%

₹ 162

-10.27%

 

 

 

 

 

 

Diluted EPS (Rs)

₹ 10.05

₹ 6.27

 

₹ 10.67

 

OPM

7.65%

8.37%

 

8.26%

 

Net Margins

3.39%

2.74%

 

3.81%

 

 

The operating margins tapered yoy from 8.37% to 7.65% due to higher operating costs and operating losses in the digital pharmacy business. Net margins improved at 3.39% compared to 2.74% in year ago period. Company declared a final dividend of Rs9 per share, with combined with the interim dividend of Rs6 per share came to total dividend of Rs15 per share.

Top stories
Company

L&T Partners with PS Technology to Revolutionise Railways

6 mins read . 02 Aug 2024 . 12:45 PM

Company

Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr

4 mins read . 02 Aug 2024 . 12:41 PM

Company

Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr

4 mins read . 02 Aug 2024 . 12:36 PM

Related Blogs
blog-logo

Share Market

blog-logo

10 mins read . 09 Dec 2024

What is the Bombay Stock Exchange?

  • 0 people read
blog-logo

Share Market

blog-logo

13 mins read . 09 Dec 2024

Stocks Under 5 Rupees in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions